Interpretation of idarucizumab clinical trial data based on spontaneous reports of dabigatran adverse effects in the French pharmacovigilance database

Albert Trinh-Duc; Albert Trinh-Duc; Agnés Lillo‐Le Louët; Agnés Lillo‐Le Louët; Éric Tellier; Éric Tellier; Thibault Viard; Thibault Viard; Grégoire Le Gal; Grégoire Le Gal; David M. Smadja; David M. Smadja

doi:10.1016/j.thromres.2016.08.014

Related publications

Article2025

Safety of venetoclax in real-world experience: data from the French national database of pharmacovigilance through all indications in hematological malignancies over 5 years

Alexis Talbot, Alexis Talbot, Pierre-Édouard Debureaux, Pierre-Édouard Debureaux, Agnés Lillo‐Le Louët, Agnés Lillo‐Le Louët, Yasmine Derri, Yasmine Derri, Marine Aroux-Pavard, Marine Aroux-Pavard, Hélène Jantzem, Hélène Jantzem, David M. Smadja, David M. Smadja, Cyrille Touzeau, Cyrille Touzeau, Christine Le Beller, Christine Le Beller, Nicolas Gendron, Nicolas Gendron

Article2007

Bisphosphonate use and osteonecrosis of the jaw: Pharmacovigilance and reporting of this serious adverse event from the Research on Adverse Drug Events and Reports (RADAR) project

Barbara Edwards, Mrinal M. Gounder, June M. McKoy, Dennis W. Raisch, Mathew Farrugia, Mário César, Robert Marx, S. Ruggiero, Meletios A Dimopoulos, Charles L. Bennett

Article2021

Neuropsychological adverse drug reactions of Remdesivir: analysis using VigiBase, the WHO global database of individual case safety reports.

S Lee, Junqing Yang, Se Yong Jung, M S Kim, Dong Keon Yon, S W Lee, Hoon‐Chul Kang, Elena Dragioti, K Tizaoui, Louis Jacob, A Koyanagi, Joe‐Elie Salem, Karel Kostev, Ana Lascu, Jae Il Shin, Ji Hong Kim, Lee Smith

Article2021

Neuropsychological adverse drug reactions of Remdesivir: analysis using VigiBase, the WHO global database of individual case safety reports

Seung Won Lee, Jae Won Yang, Sun‐Young Jung, M. S. Kim, Dong Keon Yon, S.W. Lee, Ho‐Cheol Kang, Elena Dragioti, Kalthoum Tizaoui, Louis Jacob, Ai Koyanagi, Joe‐Elie Salem, Karel Kostev, Ana Lascu, Jae Il Shin, Ji Hong Kim, Lee Smith

Letter2009

SCOUT Trial Reports on the Safety Profile of Sibutramine in Patients with Cardiovascular Diseases

Aldo Maggioni